2012 annual financial data
TG Therapeutics, Inc. 2012 Operating margin
TG Therapeutics, Inc. 2012 operating margin with verified reported values.
Direct answer
Operating margin was -141,196.45%.
Operating income was -26,895,099 USD and net income was -18,072,719 USD.
Operating cash flow was -5,187,964 USD.
Get free TG Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,048 USD
- Operating income
- -26,895,099 USD
- Net income
- -18,072,719 USD
- Operating cash flow
- -5,187,964 USD